UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Cripto Regulates Hematopoietic Stem Cells as a Hypoxic-Niche-Related Factor through Cell Surface Receptor GRP78

Cell stem cell, 2011-10, Vol.9 (4), p.330-344

2011

Link zum Volltext

Verfügbarkeit prüfen

Differences in Cell Cycle Status Underlie Transcriptional Heterogeneity in the HSC Compartment

Cell reports (Cambridge), 2018-07, Vol.24 (3), p.766-780

2018

Link zum Volltext

Verfügbarkeit prüfen

Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche

Blood, 2011-08, Vol.118 (6), p.1534-1543

2011

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia mediates low cell-cycle activity and increases the proportion of long-term–reconstituting hematopoietic stem cells during in vitro culture

Experimental hematology, 2010, Vol.38 (4), p.301-310.e2

2010

Link zum Volltext

Verfügbarkeit prüfen

HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells

Proceedings of the National Academy of Sciences - PNAS, 2009-09, Vol.106 (39), p.16805-16810

2009

Link zum Volltext

Verfügbarkeit prüfen

Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003488

2022

Link zum Volltext

Verfügbarkeit prüfen

ERG Controls B Cell Development by Promoting Igh V-to-DJ Recombination

Cell reports (Cambridge), 2019-11, Vol.29 (9), p.2756-2769.e6

2019

Link zum Volltext

Verfügbarkeit prüfen

(H)if blood stem cells gO2 sleep: What can wake them up?

Cell cycle (Georgetown, Tex.), 2011-10, Vol.10 (20), p.3419-3420

2011

Link zum Volltext

Verfügbarkeit prüfen

594 BT-001, an oncolytic vaccinia virus armed with a Treg-depleting human recombinant anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A629-A629

2020

Link zum Volltext

Verfügbarkeit prüfen

HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia

Blood, 2014-12, Vol.124 (24), p.3597-3607

2014

Link zum Volltext

Verfügbarkeit prüfen

Hypoxic Induction of Vascular Endothelial Growth Factor Regulates Fetal Erythropoiesis but Not Stem Cell Function

Blood, 2011-11, Vol.118 (21), p.4823-4823

2011

Link zum Volltext

Verfügbarkeit prüfen

(H)if blood stem cells gO 2 sleep: What can wake them up?

Cell cycle (Georgetown, Tex.), 2011-10, Vol.10 (20), p.3419-3420

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5602: BT-001, an oncolytic vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5602-5602

2020

Link zum Volltext

Verfügbarkeit prüfen

ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation

Genes & development, 2015-09, Vol.29 (18), p.1915-1929

2015

Link zum Volltext

Verfügbarkeit prüfen

Hypoxic induction of vascular endothelial growth factor regulates erythropoiesis but not hematopoietic stem cell function in the fetal liver

Experimental hematology, 2014-11, Vol.42 (11), p.941-944.e1

2014

Link zum Volltext

Verfügbarkeit prüfen

Hypoxic induction of vascular endothelial growth factor regulates erythropoiesis but not hematopoietic stem cell function in the fetal liver

Experimental hematology, 2013-08, Vol.41 (8), p.S34-S34

2013

Link zum Volltext

Verfügbarkeit prüfen

PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituents

Cell reports (Cambridge), 2022-05, Vol.39 (6), p.110793-110793, Article 110793

2022

Link zum Volltext

Verfügbarkeit prüfen

The splice factor PTBP1 regulates hematopoietic stem cell function and red blood cell development

Experimental hematology, 2016-09, Vol.44 (9), p.S95-S96

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model

Leukemia, 2012-07, Vol.26 (7), p.1527-1536

2012

Link zum Volltext

Verfügbarkeit prüfen

746 Vectorized Treg-depleting anti-CTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject “cold” tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A777-A777

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3567: Comprehensive preclinical studies of BT-001: An oncolytic vaccinia virus armed with Treg-depleting @CTLA4 and GM-CSF

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3567-3567

2022

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1[alpha] in the hypoxic bone marrow niche

Annals of the New York Academy of Sciences, 2012-08, Vol.1266 (1), p.55

2012

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Cellular Effects of Oncogene Cooperation in a Genetically Adequate AML Model

Blood, 2011-11, Vol.118 (21), p.1379-1379

2011

Link zum Volltext

Verfügbarkeit prüfen

Cripto Regulates Hematopoietic Stem Cells As a Hypoxic Niche Related Factor Through the Cell Surface Receptor GRP78

Blood, 2011-11, Vol.118 (21), p.2332-2332

2011

Link zum Volltext

Verfügbarkeit prüfen

Impaired Function of Hematopoietic Stem Cells with Abrogated Hypoxia Induced Expression of Vascular Endothelial Growth Factor

Blood, 2008-11, Vol.112 (11), p.280-280

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(29)
Tagungsberichte
(3)

Sprache

Englisch
(32)
Japanisch
(3)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cripto Regulates Hematopoietic Stem Cells as a Hypoxic-Niche-Related Factor through Cell Surface Receptor GRP78

Differences in Cell Cycle Status Underlie Transcriptional Heterogeneity in the HSC Compartment

Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche

Hypoxia mediates low cell-cycle activity and increases the proportion of long-term–reconstituting hematopoietic stem cells during in vitro culture

HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells

Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors

ERG Controls B Cell Development by Promoting Igh V-to-DJ Recombination

(H)if blood stem cells gO2 sleep: What can wake them up?

594 BT-001, an oncolytic vaccinia virus armed with a Treg-depleting human recombinant anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment

HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia

Hypoxic Induction of Vascular Endothelial Growth Factor Regulates Fetal Erythropoiesis but Not Stem Cell Function

(H)if blood stem cells gO 2 sleep: What can wake them up?

Abstract 5602: BT-001, an oncolytic vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment

ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation

Hypoxic induction of vascular endothelial growth factor regulates erythropoiesis but not hematopoietic stem cell function in the fetal liver

Hypoxic induction of vascular endothelial growth factor regulates erythropoiesis but not hematopoietic stem cell function in the fetal liver

PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituents

The splice factor PTBP1 regulates hematopoietic stem cell function and red blood cell development

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model

746 Vectorized Treg-depleting anti-CTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject “cold” tumors

Abstract 3567: Comprehensive preclinical studies of BT-001: An oncolytic vaccinia virus armed with Treg-depleting @CTLA4 and GM-CSF

Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1[alpha] in the hypoxic bone marrow niche

Molecular and Cellular Effects of Oncogene Cooperation in a Genetically Adequate AML Model

Cripto Regulates Hematopoietic Stem Cells As a Hypoxic Niche Related Factor Through the Cell Surface Receptor GRP78

Impaired Function of Hematopoietic Stem Cells with Abrogated Hypoxia Induced Expression of Vascular Endothelial Growth Factor

Suchergebnisse filtern